In this population of patients with cT1–2 rectal cancer assessed by MRI who underwent TME, there was a decreasing trend in diagnosis of cN1–2 disease after revision of the guideline in 2014 ( Fig . 2 ).
1
—
—
In this population of patients with cT1–2 rectal cancer assessed by MRI who underwent TME, there was a decreasing trend in diagnosis of cN1–2 disease after revision of the guideline in 2014 ( Fig . 2 ).